Cercare Medical is excited to announce its participation in the upcoming World Stroke Congress (WSC) 2024, which will be held from October 23-26 in Abu Dhabi, UAE.

The WSC is a pivotal event that unites the international stroke community, focused on reducing the burden of stroke through advancements in prevention, treatment, and recovery. This congress provides a unique opportunity for global professionals to come together to discuss the latest scientific research, clinical trials, breakthroughs, and guidelines in stroke care.

As a leader in developing innovative solutions for stroke management, Cercare Medical is eager to contribute to this important dialog. Our flagship product, the Cercare Medical Neurosuite, features several specialized tools designed for stroke care, including Cercare CT Stroke, Cercare CT Stroke Advanced, Cercare MR Stroke, and Cercare MR Stroke Advanced. Our platforms integrate proprietary biomarkers that not only measure heterogeneity of blood flow but also assess oxygenation, providing comprehensive insights into patient health.

Visit our booth to experience live demonstrations of our cutting-edge perfusion imaging technologies. Discover how our software solutions enhance diagnostic precision and streamline clinical decision-making processes across a range of neurological conditions.

Onsite Demo: Opportunity to engage with our technology and explore its real-world applications.

Meet our Team: Our team will be available to discuss how Cercare Medical’s innovative solutions can be smoothly incorporated into your clinical workflows.

“Brain Capillary Perfusion in Acute Ischemic Stroke: Preliminary Data for Clinical Practice and Detection of No-Reflow Phenomenon”
Dr. Ettore Nicolini MD PhD, Stroke Neurologist - Sapienza University Hospital
Wednesday, 23rd October
9 :30 – 9 :40am – WSC Theater

Cercare Medical is a provider of advanced perfusion imaging solutions. With fully automated and multi-vendor compatible software for CT and MRI perfusion imaging post-processing, we are committed to delivering cutting-edge technology that enhances patient care and advances medical diagnostics across various neurological conditions, including Stroke, Oncology, Alzheimer's, Dementia, and COVID-19. Our proprietary biomarkers allow for better, more precise imaging maps, improving decision-making in critical care and enhancing neuroimaging. This innovative technology has led to widespread adoption by leading hospitals and clinics around the world.